You have not entered a valid address outside the United States of America, Canada, Japan and Australia. We therefore regret that we cannot provide you with the desired information. Should you be a shareholder of OncoRedox please contact Investor Relations regarding further information on the rights offering at:

OncoRedox
Investor Relations
Tel: +49 6221 64924-87
E-Mail: ir@oncoredox.com